umbilical cord derived mesenchymal stem cells

BIOLOGICAL3 trials

Sponsors

University of Jordan, Trustem, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

AnemiaBleedingCOVID-19Hematologic NeoplasmsInfectionsMultiple SclerosisNeutropeniaThrombocytopenia

Phase 1

Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

CompletedNCT03326505

University of JordanMultiple Sclerosis

Start: 2017-09-25End: 2020-02-20Updated: 2020-03-04

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAnemia, Bleeding, Hematologic Neoplasms +3

Start: 2023-01-01End: 2025-01-31Target: 181Updated: 2023-01-05

Phase 2

Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia

TrustemCOVID-19

Start: 2020-07-31End: 2020-11-30Target: 30Updated: 2020-06-12

Related Papers

The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis

Medicine2020-08-1916 citations